Gavi Forecasts New TB Vaccines Saving 7.3M Lives
Analysis based on 19 articles · First reported Sep 14, 2026 · Last updated Sep 14, 2026
The announcement is positive for vaccine manufacturers and global health financiers, signaling a large future market of roughly 85 million courses annually and potential regulatory approvals by 2029. However, the impact is long-dated and contingent on financing and manufacturing capacity, so near-term equity moves in pharma are likely limited.
GAVI announced on Monday that new tuberculosis vaccines expected to become available from 2029 could save up to 7.3 million lives between 2030 and 2050, and unlock up to $135 billion in economic benefits across low- and middle-income countries. Gavi CEO Sania Nishtar called the pipeline candidates the next blockbuster immunisation tool, but warned that governments and manufacturers must prepare now to ensure sufficient, predictable and affordable supply for high-burden countries. Tuberculosis remains the world's leading infectious killer, with an estimated 10.7 million people developing the disease and 1.2 million dying in 2024, according to the World Health Organization. The only currently licensed vaccine, Bacille Calmette-Guerin, is over 100 years old and its protection wanes, leaving adolescents and adults unprotected. Gavi said demand among low- and middle-income countries could average 85 million vaccination courses annually, with higher demand in early years. The estimates are based on preliminary modelling by the London School of Hygiene and Tropical Medicine, assuming 50 percent efficacy and waning immunity over 10 years. Gavi identified risks including inadequate financing, demand uncertainty, limited manufacturer capacity and evidence gaps. It said it is working with partners, including through the WHO TB Vaccine Accelerator's Finance and Access Working Group, to lay groundwork for timely access. Separately, the Serum Institute of India signed a deal with the Gates Foundation to manufacture a novel TB vaccine candidate, and the India — Indian Council of Medical Research reported that India contributes about one-fourth of the world's TB burden.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard